4TEEN4 Announces Promising First-in-Human Data for Procizumab in Cardiogenic Shock

4TEEN4 Pharmaceuticals announced the publication of data in the European Journal of Heart Failure demonstrating the efficacy and safety of procizumab,...
Home/KnloSights/Clinical Trial Updates/4TEEN4 Announces Promising First-in-Human Data for Procizumab in Cardiogenic Shock